- Case report
- Open Access
Primary psoas abscess due to Streptococcus milleri
© Bagul et al; licensee BioMed Central Ltd. 2008
- Received: 09 December 2007
- Accepted: 26 February 2008
- Published: 26 February 2008
Primary Psoas abscess (PPA) is an infrequent clinical entity with obscure pathogenesis and vague clinical presentation. High index of clinical suspicion is required for the diagnosis of psoas abscess. We also emphasises the importance of bacteriological confirmation of microorganism involved, although Staphylococcus aureus remains the commonest pathogen. We report an extremely rare case of PPA caused by Streptococcus milleri. Only one case has been reported in literature so far.
- Percutaneous Drainage
- Serratia Marcescens
- Yersinia Enterocolitica
- Staphylococcus Aureus
- Psoas Abscess
Primary psoas abscess (PPA) is extremely rare clinical entity, which potentially carries high mortality and morbidity if diagnosis is delayed. A PPA has no obvious focus of infection, with the commonest pathogen being Staphylococcus aureus (SA). We report an extremely rare case of PPA caused by Streptococcus milleri (SM). Only one case has been reported in literature as far as our knowledge . It carries a good prognosis provided early drainage is performed and parenteral antibiotic therapy is administered to patient. High index of clinical suspicion is required for the diagnosis of psoas abscess (PA). We also emphasises the importance of bacteriological confirmation of microorganism involved.
Mynter first described psoas abscess in 1881 refereeing as psoitis . PA is a relatively uncommon condition in western countries. PA may be classified as primary or secondary, depending on the presence or absence of underlying infection. PPA occurs probably as a result of haematogenous spread of an infectious process from an occult source in the body. Incidence of PA was 12 cases per year worldwide in 1992 . This was a significant increase from the calculated occurrence of 3.9 cases per year before 1985 . The increase was attributed to improved diagnosis with the widespread use of computed tomography. PPA is most prevalent in young patients and occurs rarely in the elderly population. Certain groups of immunocompromised patients, such as diabetics, the elderly, patients on steroids, patients with malignancies, and alcoholics, usually present with infrequent sites of infection. SA is the causative organism in over 88% of patients with PPA , Streptococcus species 4.9% and Escherichia coli 2.8%. Other rare pathogens reported are Mycobacterium tuberculosis, Streptococcus species, Escherichia coli, Salmonella enteritidis, Pneumococcal, Pseudomonas aeruginosa, Proteus Mirabilis, Yersinia enterocolitica, Bacteroides, Pasteurella multocida, Klebsiella, Serratia marcescens Mycobacterium kansasii, and Mycobacterium xenopi. Methillicin resistant Staphylococcus aureus is also known pathogen .
SM is very rare organism to cause PA. It is Gram positive coccus which is usually involved in endocarditis, peritonitis, intracranial abscess, intraspinal abscess, liver abscess and lung abscess . It belongs to Streptococcus milleri group along with Streptococcus intermedius and anginosus.
The classical symptoms of patients with PPA are fever, flank or abdominal pain, and limp. The patient mentioned in our case report presented with similar symptoms. Other symptoms may include malaise, weight loss, or presentation with a mass. Physical findings, such as external rotation of the ipsilateral hip, flank tenderness, and fullness of the flank may be seen. Laboratory tests may reveal raised white cell count, anaemia, and elevated erythrocyte sedimentation rate, and bacteriological confirmation of microorganism is utmost importance.
Radiographic imaging studies help in diagnosis and may also help in finding an underlying cause. Plain abdominal x-ray may reveal an abnormal psoas shadow or a soft tissue mass. USS of the abdomen may demonstrate a hypoechoic mass suggestive of PA, but cannot identify the cause of the abscess. CT scan of the abdomen with contrast is the most efficient and accurate imaging study in diagnosing a PA. CT scanning is now used as the first line of investigation. CT scan of the abdomen not only helps in diagnosis, but also in identification of the etiology, for therapeutic purposes, and postoperative follow-up [7, 8].
An adequate knowledge of the causative organisms should guide the initial choice of antibiotics. But at the same time the importance of bacteriological confirmation of micro organism involved should not be ignored. It has been suggested that in PPA, antistaphylococcal antibiotic therapy should be started before final bacteriologic diagnosis . However, the identification of non-staphylococcus organisms in some patients with PPA and the identification of staphylococcus in patients with secondary PA, makes it prudent in all cases of psoas abscess to start treatment with broad spectrum antibiotics like cephalosporins, quinolones, imipenem and clindamycin pending final bacteriologic diagnosis . Antibiotics are sometimes continued up to four to six weeks after complete drainage of the abscess.
Drainage can be surgical or radiologically. Percutaneous drainage may be difficult in some patients because of the location of the abscess, but whenever possible it should be employed. Even in patients with complex, multiloculated abscesses, percutaneous drainage should be attempted and open surgical drainage should be reserved if percutaneous drainage fails. Patients with secondary psoas abscess require correction of their underlying disease in addition to the drainage procedure. Extraperitoneal drainage is a safe, effective method of draining these abscesses. Compared to percutaneous drainage, an advantage with open drainage is that debridement of adjacent tissues can be done, which may help in shortening recovery time . The prognosis of PPA is better compared to secondary abscess .
High index of clinical suspicion is required for the diagnosis of psoas abscess. We also emphasises the importance of bacteriological confirmation of microorganism involved, although Staphylococcus aureus remains the commonest pathogen.
Written informed consent was obtained from the patient for participation in this research.
A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Ibanez Perez de la Blanca MA, Mediavilla Garcia JD, Martinez R, Mohamed-Balghata MO, Arrebola Nacle JP, Jimenez-Alonso J: Primary abscess of the psoas muscle caused by Streptococcus milleri. Clin Infect Dis. 1992, 15 (5): 883-4.View ArticlePubMedGoogle Scholar
- Mynter H: Acute psoitis. Buffalo Med Surg J. 1881, 21: 202-210.Google Scholar
- Taiwo B: Psoas abscess: A primer for the internist: Case Report. South Med J. 2001, 94: 78-80.View ArticleGoogle Scholar
- Gruenwald I, Abrahamson J, Cohen O: Psoas abscess: case report and review of the literature. J Urol. 1992, 147: 1624-1626.PubMedGoogle Scholar
- Walsh TR, Reilly JR, Hanley E, Webster M, Peitzman A, Steed DL: Changing etiology of iliopsoas abscess. Am J Surg. 1992, 163: 413-416. 10.1016/0002-9610(92)90043-QView ArticlePubMedGoogle Scholar
- Ruoff KL: Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. Clin Microbiol Rev. 1988, 1 (1): 102-108.PubMed CentralPubMedGoogle Scholar
- Cantasdemir M, Kara B, Cebi D, Selcuk ND, Numan F: Computed tomography-guided percutaneous catheter drainage of primary and secondary iliopsoas abscesses. Clin Radiol. 2003, 58 (10): 811-5. 10.1016/S0009-9260(03)00274-5View ArticlePubMedGoogle Scholar
- Melissas J, Romanos J, de Bree E, Schoretsanitis G, Askoxylakis J, Tsiftsis DD: Primary psoas abscess. Report of three cases. Acta Chir Belg. 2002, 102 (2): 114-7.PubMedGoogle Scholar
- Santaella RO, Fishman EK, Lipsett PA: Primary vs secondary iliopsoas abscess. Presentation, microbiology, and treatment. Arch Surg. 1995, 130 (12): 1309-13.View ArticlePubMedGoogle Scholar
- Garner JP, Meiring PD, Ravi K, Gupta R: Psoas abscess – not as rare as we think?. Colorectal Dis. 2007, 9 (3): 269-74. 10.1111/j.1463-1318.2006.01135.xView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.